Approval · Notice of Compliance 12154 · 2011
PROGLYCEM: Notice of Compliance 12154
Issued March 14, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12154
- Date
- March 14, 2011
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Hyperglycemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROGLYCEM | 00503347 | Marketed |
Medicinal ingredients
- DIAZOXIDE 100 MG per CAP